[CT-guided thoracal sympathicolysis for the treatment of peripheral arterial occlusive disease and chronic thoracal pain syndromes in 6 patients].
CT-guided thoracal sympathicolysis for the treatment of peripheral arterial occlusive disease and chronic thoracal pain syndromes in 6 patients.


OBJECTIVE
Retrospective evaluation of the safety and effectivity of CT-guided percutaneous thoracal sympathicolysis (CT-TSL) in the treatment of patients with peripheral arterial occlusive disease (PAOD) of the upper limb and chronic thoracal pain syndromes. Comparison of our own experience with literature reports.


METHODS
Between 6/96 and 12/99, 4 patients with PAOD of the upper limb and two with chronic thoracal pain syndromes caused by herpes zoster were treated by unilateral CT-TSL.


RESULTS
18, 21 and 32 months after the intervention 3 out of 4 patients treated for PAOD reported subjective improvements, and one remained unchanged. Two patients treated for pain syndromes showed no long-term benefit of the procedure. There were no serious complications.


CONCLUSIONS
The CT-TSL is an alternative method in the treatment of PAOD in patients who are unsuitable for treatment by revascularization.
Finkenzeller
T
T
Abteilung Röntgendiagnostik, Klinikum der Universität Regensburg, Germany.
Techert
J
J
Lenhart
M
M
Link
J
J
Feuerbach
S
S
D000368:Aged; D001132:Arm / Q000098:blood supply; D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D002637:Chest Pain / Q000188:drug therapy*; D005260:Female; D006562:Herpes Zoster / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008619:Mepivacaine; D008875:Middle Aged; D012189:Retrospective Studies; D013563:Sympathectomy, Chemical; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D008619:Mepivacaine